Table 1.
Baseline demographic and clinical characteristics
| Patient characteristics a |
N (%) or mean (±SD)
b
|
|||
|---|---|---|---|---|
| SCORPIO (n = 1906) | ARIES (n = 1270) | CAPRICORN (n = 1251) | Pooled trials (n = 4427) | |
| Age |
59.1 (±12.4) |
60.2 (±13.4) |
59.1 (±13.0) |
59.4 (±12.9) |
| Female |
1372 (72.0%) |
950 (74.8%) |
857 (68.5%) |
3179 (71.8%) |
| BMI |
27.8 (±4.9) |
30.2 (±7.0) |
29.4 (±6.4) |
28.9 (±6.1) |
| Geographical region | ||||
| Western Europe |
1906 (54.2%) |
0 (0.0%) |
359 (28.7%) |
1392 (31.4%) |
| Eastern Europe |
873 (45.8%) |
0 (0.0%) |
222 (17.8%) |
1095 (24.7%) |
| USA |
0 (0.0%) |
127 (10.0%) |
584 (46.7%) |
1727 (39.0%) |
| Canada |
0 (0.0%) |
1143 (90.0%) |
86 (6.9%) |
213 (4.8%) |
| Previously treated with antimuscarinics |
946 (49.6%) |
714 (56.2%) |
642 (51.3%) |
2302 (52.0%) |
| Baseline mean number of micturitions per 24 h |
11.6 (±2.9) |
11.7 (±3.4) |
11.6 (±3.1) |
11.6 (±3.1) |
| Baseline mean number of incontinence episodes per 24 h | 1.7 (±2.4) | 2.1 (±2.7) | 2.3 (±2.3) | 1.8 (±2.5) |
aBMI: Body mass index; USA: United States of America.
bSD: Standard deviation.